Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

“There’s very clear evidence that screening prevents vision loss,” says Roomasa Channa, a retina specialist at the University of Wisconsin-Madison in the US. In the US barriers include cost, ...

Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the ...

Although laser photocoagulation is an effective treatment for proliferative diabetic retinopathy, few options were available at that time for wet AMD (Box 1). Visual acuity tests are the most ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

laser treatment, and vitrectomy, depending upon the severity of the condition. When it comes to diabetic retinopathy, ...

"There is a significant unmet medical need for patients suffering from diabetic retinopathy ... current treatment options consist mainly of invasive intravitreal injections and laser treatment ...

The foveal avascular zone, or FAZ, area deteriorated at 12 months in eyes with stable laser-treated proliferative diabetic retinopathy ... an RNA interference-based treatment for geographic ...

Pivotal data evaluating the safety and efficacy of the subretinal delivery of ABBV-RGX-314 in patients with wet age-related macular degeneration (wet AMD) are expected ...